INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

Context Capital Management, LLC's Holding History (CIK: 0001301396)

Note: Option positions (PUT/CALL) are excluded.

Q3 2023
Shares 23,076 Value ($000) $23 Avg Close — Range —
Q2 2023
Shares 20,230 Value ($000) $16 Avg Close — Range —
Q1 2023
Shares 20,230 Value ($000) $17 Avg Close — Range —
Q4 2022
Shares 22,730 Value ($000) $17 Avg Close — Range —
Q3 2022
Shares 19,230 Value ($000) $14,382 Avg Close — Range —
Q2 2022
Shares 9,795 Value ($000) $6,281 Avg Close — Range —
Q1 2021
Shares 7,985 Value ($000) $5,236 Avg Close — Range —
Q4 2020
Shares 7,485,000 Value ($000) $4,494 Avg Close — Range —
Q3 2020
Shares 7,485,000 Value ($000) $5,145 Avg Close — Range —
Q2 2020
Shares 1,985,000 Value ($000) $1,424 Avg Close — Range —
Q1 2020
Shares 985,000 Value ($000) $863 Avg Close — Range —
Q4 2019
Shares 3,485,000 Value ($000) $4,611 Avg Close — Range —
Q3 2019
Shares 4,985,000 Value ($000) $4,480 Avg Close — Range —
Q2 2019
Shares 2,500,000 Value ($000) $2,486 Avg Close — Range —